StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) stock

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$91.95+0.37 (+0.40%)

Close on Nov 17, 2026Market cap $5.97BP/E –Yield –

Mirum Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Mirum Pharmaceuticals's price to sales ratio was 9.9× on Nov 11, 2026, against 7.9× a year earlier. Over the last 5 years it ranged from 5.8× to 38.0×, with a median of 10.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.9×+1.3
2025Dec 31, 20258.6×+2.1
2024Dec 31, 20246.5×−11.4
2023Dec 29, 202317.8×+4.1
2022Dec 30, 202213.7×−16.6
2021Dec 31, 202130.3×–

More Mirum Pharmaceuticals figures

See a number that looks wrong?